Building Biotechs

This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success.Get Renee's recommended book! The 3-Minute Rule: Say Less to Get More from Any Pitch or PresentationLink In with Renee!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Childhood Dreams01:19 The Power of Dressing the Part01:49 Career Path and Consulting Firm03:20 Role of a Fractional CBO04:03 Navigating Startup Challenges06:07 Crafting Effective Pitch Decks08:32 Big Pharma vs. Biotech Mentality16:01 The Importance of a Strong Team in Biotech16:20 Approaching Pharma and Corporate Venture Capital17:20 Strategies for Biotech Companies to Gain Traction18:24 Types of Biotech CEOs and Their Approaches21:02 Navigating Conferences and Networking27:09 Future Goals and Aspirations28:59 Book Recommendations and Closing Thoughts

This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders.Get Natalie's recommended book! The Book of Delights: EssaysCYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect | Nature CommunicationsConnect with Natalie on LinkedIn!Learn more about Cyclera TherapeuticsConnect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Early Aspirations00:33 Journey into Biomedical Engineering01:19 First Startup Experience03:40 Founding Cyclera05:02 Focus on CNS Therapeutics13:35 Challenges and Strategies in Biotech15:39 The Termeer Foundation Fellowship21:26 Biotech Networks: Boston vs. Seattle26:50 Future of Cyclera and Personalized Medicine32:45 Conclusion and Final Thoughts

In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical engineering, and her experience with successful biotech exits. Experience from previous startups profoundly informs StimulusBio’s approach to helping startups transition from incubation to market. We explored the critical stages of startup growth, emphasizing the importance of marketing, storytelling, team building, and experience-based advice. Stacie also shared her insights into the emerging trends in the biotech industry, particularly in Houston's growing biotech ecosystem, and the importance of balancing innovation with practical business needs.Get Stacie's recommended book! Think Again: The Power of Knowing What You Don't KnowLearn about StimulusBioConnect with Stacie on LinkedIn!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Stacie Frye and StimulusBio00:51 Stacie's Unique Career Path01:56 Early Career and Transition to Bioengineering03:32 Startup Experiences and Lessons Learned08:46 Challenges in Transitioning from Incubator to Market12:44 The Importance of Marketing and Team Building32:17 Emerging Trends and Future Goals37:09 Conclusion and Contact Information

This week, I had an insightful conversation with David Sans, PhD, FAARM, MBA, who heads healthcare investment banking at EF Hutton. We discussed the intricacies of different Public Offering strategies, including micro IPOs, which offer a unique avenue for biotech companies. David provides a deep perspective on the strategic implications of IPOs for biotech funding. He emphasized the importance of investor support and strategic banking partnerships, especially for micro IPOs. We also discussed the potential of AI in reshaping financial services and the future of outcome-based pricing models in investment. David's personal insights reveal the demanding yet rewarding nature of investment banking and highlight crucial aspects to consider for those pursuing a career in this field. Get David's recommended book: Barcelona, Catalonia: A View from the InsideLearn more about EF Hutton LLC!Link In with David!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Biotech and Investment Banking00:48 David Sands' Background and Career Journey02:12 Transition from Biotech to Finance04:53 Understanding Micro IPOs06:37 Challenges and Strategies in Biotech IPOs16:38 The Role of the FDA in Biotech IPOs18:30 Understanding IPO Disparities18:42 Key Factors for a Successful IPO19:29 Aftermarket Support and Investor Relations20:59 The Role of Long-Term Investors21:34 Personal Investment Strategies22:29 Innovations in Financial Services24:40 Challenges for Biotech CEOs26:32 Career Path in Investment Banking28:50 Future of Financial Services and AI33:37 Book Recommendations and Closing Thoughts

This week I had a great conversation with Iva Toudjarska, founder and CEO of Zeal Therapeutics. From earning a PhD in molecular biology to a solid scientific career at Alnylam, to working in venture capital, to selling a successful SaaS company, Iva’s career that’s set her up well to enjoy this new challenge – founding a baby biotech. Her expertise marries business development, venture capital, and company-building. Iva shared valuable advice for biotech founders on securing funding, making strategic decisions, and building effective partnerships. Tune in to hear her experiences, lessons learned, and her current work leading Zeal Therapeutics, a precision kidney RNA therapeutics company.Get Iva's favorite book! The AlchemistLink In with Iva!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 - Intro to Iva Toudjarska's Career00:48 - Career overview, Iva Toudjarska, Zeal Therapeutics04:26 - Successful biotech strategies, industry insights07:02 - Building successful partnerships, collaboration tips12:15 - Angel investing, funding strategies, biotech financing20:20 - Leveraging background, skills for biotech success24:38 - Setbacks in biotech, lessons learned, resilience27:20 - Bootstrapping a company, startup funding, entrepreneurship28:23 - Support for Eva, mentorship, biotech advice29:18 - Future goals, biotech vision, 10-year plan30:45 - Current reading, professional development, industry literature24:24 Lessons Learned and Future Goals28:08 Conclusion and Final Thoughts

This week I had a fun conversation with Jason Cordeiro, Chief Operating and Innovation Officer at MassBio. We dissect MassBio's newly announced five-year strategic plan that includes a multi-pronged set of initiatives aimed at advancing the biotech industry. From supporting early-stage startups to advocating for policy changes and fostering talent development, Jason details the excellent resources available and in development. Whether you're based in Massachusetts or global, this session provides valuable information on how MassBio is working to catalyze innovation and growth in biotech, and how you can leverage these opportunities.00:00 - Intro01:24 - Jason Cordeiro, MassBio’s COO02:48 - What is MassBio05:54 - MassBio’s MassCONNECT Program08:15 - MassCONNECT Support for Non-Local Companies13:15 - How to Get Involved in MassBio17:24 - Next Level One Initiative19:58 - MassBio Align Summit Overview21:40 - Educating Investors through MassBio27:11 - MassBio Pharma Days Event31:00 - The Link Program34:54 - MassBio’s 5-Year Strategic Plan41:14 - Connecting with MassBio Resources42:11 - OutroLearn about Align Summit - MassBioLearn about Partnering Opportunities - MassBioLearn about the CEO & Founder Link - MassBioLearn about MassBio’s Vision 2030 strategic planLearn about MassBioDrive!Learn about MassBio InnovationLearn more about Massachusetts Biotechnology CouncilLinked In with Jason!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub

In this episode, we revisit a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral. Mike outlines the essentials for startups, including funding, lab space, mentorship, and resources. He shares his journey from aspiring architect to an architect of biotech ecosystems, detailing his experiences with MassChallenge and LabCentral. Mike offers insights into the key elements that make thriving ecosystems, like government support, industry collaboration, and a density of entrepreneurs. He also discusses how LabCentral supports startups through challenging markets, diverse talent acquisition, and successful graduations. The episode concludes with a lighthearted look at LabCentral's unique culture and the balance between hard work and fun.Learn about LabCentralConttect: Michael LaRhette - LabCentralConnect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Episode Overview00:49 Meet Mike LaRhette: From Architect Aspirations to Ecosystem Builder01:59 Journey into the Biotech Sector04:34 A Day in the Life at LabCentral07:32 The Human Side of Biotech Entrepreneurship09:55 LabCentral Ignite: Bridging Talent and Opportunity12:08 Effective Communication Strategies at LabCentral18:13 Key Elements of a Successful Ecosystem24:30 Debunking Myths About Entrepreneurs25:58 Challenges in Post-COVID Event Engagement26:58 Navigating the Tight Market28:35 Golden Tickets Program30:40 Support for New Founders at LabCentral33:16 Transitioning Out of LabCentral36:22 Balancing Fun and Seriousness at LabCentral40:00 Future Directions and Personal Growth41:49 Favorite Books and Final Thoughts

This week I spoke with Bogdan Knezevic, founder of Kaleidoscope Bio, about optimizing biotech workflows and achieving milestones efficiently. Bogdan shared insights into how his platform helps companies manage research and development processes, reducing operational inefficiencies and saving time, resources, and money. He discussed the importance of setting clear goals, breaking down complex workflows, and avoiding shiny object syndrome (a common ailment among scientists). Bogdan also emphasized the value of keeping teams focused and aligned, leveraging automation, and integrating existing tools to minimize manual work. We explored how to empower teams, balance short-term and long-term goals, and pivot gracefully when needed. Additionally, Bogdan touched on the importance of understanding the true cost of operations and making strategic investments in tools that drive productivity. Exhalation: StoriesGet Bogdan's recommended book! Stories of Your Life and OthersBiotech inflection points framework resource:Biotech fundraising milestones resourceLearn more about Kaleidoscope!Link In with Bogdan!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Systems and Workflow01:10 Meet Bogdan Knezevic: From Childhood Dreams to Biotech CEO02:22 The Frustration and Vision Behind Kaleidoscope Bio04:01 Use Cases and Value Propositions for Biotech Companies07:50 Empowering Teams and Setting Priorities11:38 Balancing Short-Term and Long-Term Goals18:22 Reducing Operational Overhead and Streamlining Processes31:07 Common Mistakes and Lessons for Biotech Leaders36:19 Book Recommendations and Closing Thoughts

This week I spoke with Jon Hu, CEO and co-founder of Pepper Bio, about his journey from pharma consulting and venture capital to founding a tech-enabled biotech company. Pepper Bio created an AI and machine learning platform accelerating drug discovery for untreatable diseases. In addition to the platform, Pepper is currently navigating their asset for liver cancer into phase 2 clinical trials. Jon highlighted the differences between tech and biotech, emphasizing the importance of dreaming big and aligning vision with employees. He shared insights on the importance of hiring, learning to learn, and overcoming challenges in transitioning from tech-enabled discovery to drug development. We also discussed Pepper Bio's computational platform, long-term strategy, and their Series A fundraising to support their clinical trial efforts. Jon’s personal story of family health challenges driving his passion for biotech underscored the company's mission to transform patient care.Start with Why: How Great Leaders Inspire Everyone to Take ActionGet Jon's recommended book! What Do You Do With an Idea? New York Times best sellerLearn more about Pepper BioLink In with Jon!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to John Hu and Pepper Bio00:54 John's Early Aspirations and Career Path02:27 Founding Pepper Bio and Its Mission05:15 Tech vs. Biotech: Ambitions and Challenges10:42 Project Optimist and Pepper's Role11:53 Pepper's Computational Platform and Future Goals16:14 Navigating the Biotech Industry and Hiring Strategies33:35 Personal Motivations and Future Aspirations36:03 Book Recommendations and Closing Remarks

This week we chatted with Cheri Ackerman, PhD, Cofounder & CEO of Concerto Biosciences. During her postdoctoral work at MIT, she developed the groundbreaking kChip technology that led to the formation of Concerto Biosciences. We discuss the challenges and opportunities of building a company during the pandemic and the importance of learning the business side of biotech as a scientific founder. As always, we trumpet the value of building a network to leverage during the growth process. Cheri gives really great advice for aspiring entrepreneurs, which is to keep learning and embrace asking questions when you don’t know something. I also loved her views on adapting and experimenting in business, which is one of the key values at Concerto. 00:00 Introduction and Early Career Aspirations00:09 Journey to Becoming a CEO01:12 Founding Concerto Biosciences02:31 Understanding the Microbiome04:56 Concerto's Innovative Approach07:53 Challenges and Opportunities in Building a Company08:58 Navigating the Funding Climate13:00 Building a Strong Team21:57 Advice for Aspiring Entrepreneurs29:34 Future Goals and Aspirations31:55 Conclusion and Contact InformationGet Cheri's recommended books! Measure What MattersThe Founder's Dilemmas: Anticipating and Avoiding the Pitfalls That Can Sink a Startup (The Kauffman Foundation Series on Innovation and Entrepreneurship, 13)No Rules Rules: Netflix and the Culture of ReinventionGood to Great: Why Some Companies Make the Leap...And Others Don'tWhoLearn more about Concerto BiosciencesLink In with Cheri!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub

This week I sat down with Krysta Pellegrino, Chief Client Officer at Health+Commerce, a public relations and marketing agency specifically focused on healthcare. Krysta shared her unique perspective on how biotech companies can leverage communications strategies to tell their stories effectively, attract talent, and navigate complex challenges. She offered insights on the importance of integrated communications, the evolving landscape of media, and how agencies like H+C can help startups and established companies alike build their brands and communicate their innovations. We also touched on the importance of media training, investor pitch decks, and future trends in biotech communications, including the growing role of AI and integrated digital strategies.00:00 Introduction and Guest Welcome00:15 Early Career Aspirations and Path01:03 Journey in Healthcare Communications03:23 Role and Impact of PR in Biotech05:40 Talent Acquisition and Company Culture07:43 Leveraging Social Media and Video10:52 Strategies for Startups and Established Companies18:16 Investor Relations and Pitch Decks22:02 Media and Presentation Training27:01 Future Trends in Biotech Communications31:37 Crisis Management and Scenario Planning35:19 Conclusion and Final ThoughtsGet Krysta's recommended book: An Instance of the FingerpostLearn more about Healthcare Digital Marketing Agency | Health+CommerceLink In with Krysta!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub

In this episode, I had the privilege to interview Bonnie Bertolaet, Ph.D, Executive Director of Science Club for Girls, and Ashley Cooper, MS, MPhil, Curriculum Writer and Evaluation Manager at Science Club for Girls and former Co-Director of the Harvard Chapter of Science Club for Girls. Science Club for Girls aims to ignite excitement, confidence, and literacy in STEM among girls and gender-expansive youth from underrepresented communities. Bonnie and Ashley shared insights into how the organization operates, from engaging young students through hands-on activities to providing valuable mentorship opportunities for biotech employees. They discussed the importance of starting STEM education early, the transformative impact of mentorship, and the ways companies can get involved and contribute. Success stories and the personal experiences of the guests offered a powerful testament to the program's effectiveness in fostering a diverse and inclusive pipeline for future scientists.Link In with Ashley!Learn more about Science Club for GirlsLink In with Bonnie! Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to the Episode00:51 Meet the Guests: Bonnie and Ashley02:37 What is Science Club for Girls?03:47 Engaging Young Minds in STEM10:26 Mentorship and Corporate Engagement21:06 Success Stories and Impact23:16 Virtual Clubs and Future Expansion26:22 How to Get Involved and Support32:01 Recommended Reads and Final Thoughts

In this episode, we had the pleasure of welcoming back Lynn Walder, our first repeat guest, to dive into the pitfalls and best practices of defining culture and core values for growing companies. There has been a shift in how companies invest in and operationalize culture over the past two decades. Lynn shares insights from her extensive experience, including the importance of early core value implementation, the challenges of aligning leadership actions with stated values, and the need for clear communication and accountability. We also discuss various assessments Lynn uses to help biotech companies define and uphold their foundational values, and how these values guide companies through times of change and crisis. Learn more about Executive Management PartnersLink In with Lynn!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Welcome Back00:34 The Evolution of Culture in Biotech03:01 Defining and Implementing Core Values05:52 Challenges in Aligning Leadership with Core Values10:27 The Importance of Early Implementation16:32 Assessments and Frameworks for Leadership23:59 Operationalizing Values in Biotech37:49 Transparency and Communication in Leadership39:58 Conclusion and Contact InformationMentioned in this episode:lynn walder intro

Today, I had the opportunity to speak with Amogha Tadimety, PhD, CEO, and Alison Burklund, PhD, President & CTO, co-founders of Nanopath, an innovative company specializing in women’s health diagnostics. Both hailing from Dartmouth’s Thayer School of Engineering, Amogha and Alison walk us through the challenges and opportunities of founding a diagnostic company during the COVID era. We chatted about the intricacies of bringing foundational technology to consumers, including the importance of navigating the insurance system and the specific focus of their technology on improving point-of-care diagnostics in women's health. They highlighted the need for innovative tools in OB-GYN practices, the strategic decisions that shaped Nanopath's direction, and the significant milestones they have achieved. They also emphasized the importance of building a strong team and network, overcoming healthcare system challenges, and their vision for the company's future, which includes creating a comprehensive well-woman panel and expanding the technology for broader applications.Get Alison's recommended book: The Fourth Turning is hereGet Amogha's recommended book: Remarkably Bright Creatures: A Read with Jenna PickLink In with Alison!Link In with Amogha!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Nanopath Founders00:59 Career Paths and Early Inspirations01:42 The PhD Innovation Program02:16 Founding Nanopath: The Journey Begins04:58 Nanopath's Mission and Technology08:13 Navigating the Healthcare System10:14 Challenges and Opportunities During COVID-1916:05 Building a Strong Team and Network24:02 Future Vision and Goals25:38 Reading Recommendations and Closing Thoughts

In this episode, I sat down with Ben Hemani from Bison Ventures, a venture capital firm that invests in early-stage frontier technology companies. We explore his background in environmental engineering and his transition into the venture capital world, driven by a passion for technology and sustainability. Ben elaborates on the interconnected areas Bison Ventures invests in, such as biotech, high-performance computing, and climate sustainability, emphasizing the critical role cross-pollination plays in innovation. We explore the nuances of assessing early-stage companies, focusing on the importance of founder teams, technical maturity, and long-term planning. Ben also shares insights on the current funding landscape and the strategic support Bison Ventures offers its portfolio companies.Get Ben's favorite book at the moment! Expecting Better (The ParentData Series Book 1) by Emily OsterLink In with Ben!Bison VenturesConnect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Ben Hemani and Bison Ventures00:34 Ben Hemani's Background and Career Path02:48 Transition into Venture Capital04:37 Overview of Bison Ventures06:13 Investment Strategies and Challenges14:49 Supporting Founding Teams19:11 Life Cycle of Portfolio Companies23:07 Current Trends and Future Prospects25:34 Day in the Life of a VC27:05 Personal Insights and Recommendations28:21 Conclusion and Contact Information

This week I sat down with Krisha Panchalingham, Director of Lab and Scientific Operations at Portal Innovations. Krisha shares how she and her team support early-stage biotech companies through the operational intricacies of setting up labs, handling logistics, maintaining equipment, and complying with regulations. We also discuss the importance of vendor management, the role of external consultants, and the strategic partnerships required to efficiently run lab operations. Krisha also emphasizes the significance of mentorship and the strategic role of operational support in the success of biotech startups. We also discuss how Portal Innovations fosters a nurturing ecosystem for biotech startups, underscoring the balance between scientific discovery and operational excellence.Get Krisha's recommended book! A Walk in the Woods: Rediscovering America on the Appalachian Trail (Official Guides to the Appalachian Trail)Boston Globe: The promise of biotech jobs is coming to Boston’s neighborhoods - MassBioLink In with Krisha!Portal Innovations LLCConnect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Krisha Penchalingham and Portal Innovations00:57 Krisha's Journey: From Childhood to Biotech03:58 Role and Responsibilities at Portal Innovations04:24 Supporting Early-Stage Biotech Companies06:20 Challenges and Successes in Lab Operations07:47 Team Dynamics and Growth at Portal Innovations08:28 Expanding Ecosystems and Future Plans22:26 Mentorship and Career Advice27:31 Conclusion and Contact Information

This week, Carina Clingman, PhD, Founder and Principal of Recruitomics Consulting, outlines an actionable 3-Step framework to simplify the recruitment process and hire top-quality talent. The discussion covers common challenges faced by small companies, such as desperation hiring and inefficiencies, and offers solutions like implementing applicant tracking systems (ATS), streamlining processes, and leveraging data-driven hiring. The episode also emphasizes the significance of proper training and compliance in conducting fair and effective interviews. Listeners will learn how to audit current processes, install a sustainable hiring engine, and ensure they attract and select the best talent, even on a limited budget.Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction: The Importance of Talent in Biotech00:54 Why Systems Matter in Talent Acquisition02:05 Common Challenges in Small Companies04:20 The Concept of Chicken Math in Startups07:58 Auditing Your Hiring Process09:31 Building a Sustainable Hiring Engine10:54 The Role of Applicant Tracking Systems19:08 The Importance of Training and Legalities24:31 Data-Driven Hiring Decisions31:42 Conclusion: Implementing Effective Hiring Strategies

This week I chatted with Oriana Papin-Zoghbi, CEO and co-founder of AOA Dx. Oriana shares insights on the challenges of fundraising and the importance of building a network for startup success. She highlights her career shift from biochemistry to economics and international relations, finally leading to her involvement in women's health diagnostics. Oriana emphasizes the significance of finding one's passion for excelling in their field and the role of previous startup successes in her current venture. I also loved learning more about AOA Dx's mission to revolutionize women's health diagnostics, focusing on unmet needs such as early ovarian cancer detection through innovative biomarker research. Oriana highlights the impact of leadership, resilience, and the pursuit of innovation in healthcare.Get Oriana's recommended book! Shoe Dog: A Memoir by the Creator of NikeLink In with Oriana!AOA DX – Early cancer detectionConnect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Oriana Papin-Zoghbi and AOA DX00:37 Oriana's Journey: From Aspiring Doctor to Women's Health Innovator04:06 Challenges and Triumphs in Women's Health Innovation07:38 The Founding of AOA DX: A Mission to Transform Women's Health07:57 Lessons Learned from Successful Exits and Setting Up AOA DX09:28 AOA DX's Vision and Mission: Advancing Women's Health Diagnostics12:57 Fundraising Journey: Overcoming Skepticism and Building Trust15:21 Leveraging Business Development Skills in Fundraising16:31 Y Combinator Experience and the Value of Community18:23 Advice for Aspiring Founders in Women's Health20:29 Future Plans for AOA DX and Personal Aspirations23:48 Oriana's Reading Recommendations and Closing Thoughts

This week, I chatted with leadership advisor, speaker, entrepreneur, and podcast host Tony Martignetti, MBA, CPC, Founder, and Chief Inspiration Officer of Inspired Purpose Partners. We both agree there’s a critical need for more comprehensive coaching and support for leaders in the biotech industry. Drawing from his diverse career that spans from art to finance and biotech, Tony shares insights into how leaders can become more grounded. He highlights his three Cs of grounded leadership - Connection, Curiosity, and Compassion - and underscores the significance of mental health, adapting to rapid change, and maintaining authenticity in the workplace. These qualities, he argues, are paramount for building strong companies and navigating the complexities of leadership in fast-evolving sectors like biotech.Get Tony's favorite book: The Art of Possibility: Transforming Professional and Personal LifeTony Martignetti: books, biography, latest updateFollow Tony on Social!Inspired Purpose PartnersLink In with Tony!Ted TalkPodcast - Inspired Purpose PartnersCampfires of Connection - Inspired Purpose CoachingConnect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Tony Martignetti: A Multifaceted Leadership Advisor00:11 The Importance of Leadership Coaching in Biotech00:57 Tony's Journey: From Childhood Dreams to Leadership Advisory02:37 The Pivotal Shift: Embracing Leadership Advisory After Burnout04:42 Addressing Burnout: Personal Insights and Industry Observations08:06 Navigating Post-Pandemic Challenges and Emphasizing Connection11:11 The Three Cs of Grounded Leadership: Connection, Curiosity, Compassion25:17 Incorporating Experience Design in Leadership Coaching27:58 Campfire Lessons for Leaders: Tony's Book and Vision for the Future35:44 Final Thoughts and Resources for Aspiring Leaders

In this episode, Heather E. Williams, PhD, MBA, MS, PgD, ErCLG, CG (ASCP) MB, the Chief Operating Officer of Cache DNA, chats about her career journey and the importance of always learning. Heather's passion for medicine and genetics has led her from childhood dreams of being like Dr. Quinn, Medicine Woman to training as a clinical laboratory geneticist and eventually becoming a COO. She talks about the value of making connections, grabbing every chance to learn, and how genetic results can really make a difference in patient care. Tune in to hear more about Heather's career story and get a sneak peek into what she does at Cache DNA.Get Heather's favorite book: The Poisonwood Bible: A NovelLink In with HeatherCache DNAConnect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Guest Overview00:30 Heather's Early Career Aspirations01:28 Current Role at CacheDNA02:34 Building and Leading a Team03:36 Transition to Flagship and Executive MBA07:27 Gene Between and Endless Frontier Labs11:28 Networking and Mentorship Insights21:29 Challenges in Precision Medicine28:27 Future Goals and Book Recommendations30:46 Conclusion and Contact Information